[sixty one] shown which the CRISPR/Cas9 system could particularly goal and cleave conserved regions in the HBV genome, leading to sturdy suppression of viral gene expression and replication the two in vitro and in vivoThey discovered that Cas9-mediated base editing is a possible technique to cure CHB by completely inactivating built-in HBV DNA and